Peter Q Eichacker Selected Research

raxibacumab

1/2021	A Review of the Efficacy of FDA-Approved B. anthracis Anti-Toxin Agents When Combined with Antibiotic or Hemodynamic Support in Infection- or Toxin-Challenged Preclinical Models.
12/2015	Raxibacumab augments hemodynamic support and improves outcomes during shock with B. anthracis edema toxin alone or together with lethal toxin in canines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Q Eichacker Research Topics

Disease

47	Sepsis (Septicemia) 12/2021 - 09/2002
19	Anthrax 01/2021 - 04/2004
17	Edema (Dropsy) 01/2021 - 11/2005
17	Shock 01/2021 - 04/2004
16	Infections 11/2021 - 07/2003
12	Septic Shock (Toxic Shock Syndrome) 01/2021 - 06/2004
5	Inflammation (Inflammations) 11/2020 - 03/2006
4	Pneumonia (Pneumonitis) 12/2021 - 11/2003
4	Staphylococcal Pneumonia 12/2021 - 07/2003
4	Hypotension (Low Blood Pressure) 11/2017 - 08/2006
4	Lung Injury 05/2011 - 11/2003
3	Body Weight (Weight, Body) 01/2018 - 03/2003
3	Critical Illness (Critically Ill) 12/2014 - 09/2002
2	Bacterial Infections (Bacterial Infection) 02/2020 - 11/2003
2	Disseminated Intravascular Coagulation 10/2013 - 09/2013
2	Thrombosis (Thrombus) 05/2011 - 06/2004
2	Hemorrhage 01/2009 - 01/2009
1	Neoplasms (Cancer) 01/2022
1	COVID-19 01/2022
1	Virus Diseases (Viral Diseases) 11/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Human Influenza (Influenza) 01/2020
1	Obesity 01/2020
1	Soft Tissue Infections 01/2017
1	Acute Lung Injury 10/2014
1	Necrosis 10/2013
1	Bacteremia 12/2012

Drug/Important Bio-Agent (IBA)

10	AntigensIBA 01/2021 - 02/2005
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 02/2010
8	Protein CIBA 01/2009 - 09/2002
7	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2020 - 11/2002
6	edema factorIBA 01/2021 - 02/2007
6	LipopolysaccharidesIBA 01/2020 - 03/2006
6	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2014 - 06/2004
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013 - 03/2003
5	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2021 - 02/2007
5	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2020 - 07/2004
4	anthrax toxin (anthrax lethal factor)IBA 01/2021 - 06/2007
4	Lactic Acid (Lactate)FDA LinkGeneric 02/2020 - 01/2012
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2017 - 12/2004
4	Monoclonal AntibodiesIBA 06/2011 - 02/2005
4	CytokinesIBA 05/2011 - 04/2004
3	Immune Checkpoint InhibitorsIBA 01/2022 - 02/2020
3	adefovirIBA 01/2021 - 03/2011
3	Peptidoglycan (Murein)IBA 11/2020 - 09/2013
3	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 11/2017 - 07/2013
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 04/2004
3	Pharmaceutical PreparationsIBA 09/2014 - 08/2006
3	GlucocorticoidsIBA 01/2012 - 07/2004
3	E5564IBA 04/2011 - 03/2006
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2005 - 09/2002
2	raxibacumabIBA 01/2021 - 12/2015
2	Anthrax Immune Globulin IntravenousIBA 01/2021 - 01/2017
2	Saline SolutionIBA 10/2017 - 06/2007
2	Immunoglobulins (Immunoglobulin)IBA 10/2017 - 09/2014
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2014 - 01/2012
2	AldosteroneIBA 12/2014 - 01/2012
2	Coloring Agents (Dyes)IBA 07/2012 - 12/2011
2	Heroin (Diamorphine)IBA 07/2012 - 12/2011
2	Heparin (Liquaemin)FDA LinkGeneric 05/2011 - 04/2009
2	eritoranIBA 04/2011 - 01/2010
2	ethyl pyruvateIBA 08/2009 - 04/2008
2	parthenolideIBA 08/2009 - 03/2006
2	NF-kappa B (NF-kB)IBA 08/2009 - 04/2008
2	CreatinineIBA 01/2009 - 03/2003
2	CoagulantsIBA 01/2009 - 06/2004
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2007 - 02/2007
2	EndotoxinsIBA 03/2006 - 03/2003
2	AnticoagulantsIBA 04/2005 - 06/2004
2	Bacterial ToxinsIBA 04/2004 - 03/2003
1	LigandsIBA 12/2021
1	Programmed Cell Death 1 ReceptorIBA 12/2021
1	Antiviral Agents (Antivirals)IBA 11/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2021
1	Chloroquine (Aralen)FDA LinkGeneric 11/2021
1	obiltoxaximabIBA 01/2021
1	AntitoxinsIBA 01/2021
1	cyclopropapyrroloindoleIBA 02/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	ExotoxinsIBA 12/2017
1	SodiumIBA 01/2017
1	Cyclic AMP (AMP, Cyclic)IBA 01/2017
1	Dihydrotachysterol (AT 10)IBA 12/2014
1	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2014
1	boldenone undecylenate (Equipoise)IBA 10/2014
1	Metalloproteases (Metalloproteinases)IBA 10/2013
1	AntibodiesIBA 10/2013
1	Dacarbazine (DIC)FDA LinkGeneric 09/2013
1	Oxacillin (Prostaphlin)FDA LinkGeneric 12/2012
1	Interleukin-6 (Interleukin 6)IBA 12/2012
1	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2012
1	MineralocorticoidsIBA 01/2012
1	QuinolonesIBA 12/2011
1	CytoFabIBA 11/2011

Therapy/Procedure

31	Therapeutics 01/2022 - 11/2002
2	Early Goal-Directed Therapy 08/2015 - 02/2010
1	Punctures 01/2020
1	Ligation 01/2020
1	Controlled Hypotension 11/2017
1	Patient Care Bundles 10/2013